Clinical Study of Z-213 in Subjects With Iron-deficiency Anemia

Status:
Completed

Trial end date:
2017-12-01

Target enrollment:

Participant gender:

To confirm the safety and efficacy of Z-213 until 12 weeks after start of Z-213 administration in patients with iron deficiency Anemia

Phase 3

Zeria Pharmaceutical